Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia-Reference-Cited by-同舟云学术

Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Published:2022-01-18 Issue:2 Volume:99 Page:93-104
ISSN:2059-2302
Container-title:HLA
language:en
Short-container-title:HLA

Author:

Closa Laia¹²^ORCID,Xicoy Blanca³,Zamora Lurdes³,Estrada Natalia³,Colomer Dolors⁴,Herrero Maria J.¹,Vidal Francisco²⁵⁶^ORCID,Alvarez‐Larrán Alberto⁷,Caro Jose L.⁸

Affiliation:

1. Histocompatibility and Immunogenetics Laboratory Blood and Tissue Bank Barcelona Spain

2. Transfusional Medicine Group Vall d'Hebron Research Institute‐Autonomous University of Barcelona (VHIR‐UAB) Barcelona Spain

3. Department of Hematology Institut Català d'Oncologia, Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona Badalona Spain

4. Hematopathology Section Hospital Clinic, IDIBAPS, CIBERONC Barcelona Spain

5. Congenital Coagulopathy Laboratory Blood and Tissue Bank Barcelona Spain

6. CIBER of Cardiovascular Diseases Madrid Spain

7. Hematology Department Hospital Clinic, Institut de Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona Barcelona Spain

8. Department of Immunology Hospital Clínic Barcelona Spain

Publisher

Wiley

Subject

Genetics,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tan.14515

Reference45 articles.